Music During ESWL for Half Treatment

Sponsor
Azienda Ospedaliera Città della Salute e della Scienza di Torino (Other)
Overall Status
Completed
CT.gov ID
NCT04338451
Collaborator
(none)
70
1
2
8.7
8

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate if music listening relieves pain and discomfort during Extracorporeal Shock-Waves Lithotripsy (ESWL).

Condition or Disease Intervention/Treatment Phase
  • Other: Music during the first part of ESWL
  • Other: Music during the second part of ESWL
N/A

Detailed Description

Patients undergoing ESWL and interested in music listening are randomly divided in two groups: patients in group A listen to music during the first part of the treatment (first 1800 SW), patients in group B during the second part.

At the end of the treatment patients are asked to fill in a questionnaire. They are asked if they were pleased to have had the opportunity to listen to music during ESWL, if they would like to listen to music again in case of further treatments, if they consider music helpful in relieving pain and discomfort during ESWL. Patients are also asked to mark their level of pain during each part of the treatment on a visual analogue scale (VAS) for pain.

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Music Listening to Decrease Pain and Discomfort During Extracorporeal Shock Wave Lithotripsy (SWL): a Prospective Randomized Trial.
Actual Study Start Date :
Feb 2, 2017
Actual Primary Completion Date :
Oct 25, 2017
Actual Study Completion Date :
Oct 25, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Music during the first part of ESWL

Patients listen to music during the first part of ESWL treatment (first 1800 SW).

Other: Music during the first part of ESWL
Music listening during first part of ESWL

Active Comparator: Music during the second part of ESWL

Patients listen to music during the second part of ESWL treatment.

Other: Music during the second part of ESWL
Music listening during second part of ESWL

Outcome Measures

Primary Outcome Measures

  1. percentage of patients who appreciated music listening during SWL without anesthesia [10 mins after SWL treatment completed]

    patients were asked if they appreciated music listening during swl

Secondary Outcome Measures

  1. percentage of patients who considered music useful to relieve pain [10 mins after SWL treatment completed]

    patients were asked if they considered music useful to relieve pain during swl

  2. change in SW voltage (kV) [10 mins after SWL treatment completed]

    change in SW voltage (kV)

  3. change in VAS score [10 mins after SWL treatment completed]

    Visual analogue scale (VAS) - 0 to 10, higher values, worse pain

  4. change in analgesic request [10 mins after SWL treatment completed]

    change in analgesic request

  5. change in requested interruptions [10 mins after SWL treatment completed]

    change in requested interruptions

  6. change on VAS scores separately measured in each part of the treatment [10 mins after SWL treatment completed]

    Visual analogue scale (VAS) - 0 to 10, higher values, worse pain

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients undergoing ESWL from February 2011 to October 2012 and interested in music listening
Exclusion Criteria:
  • Contraindication to ESWL

  • No interest in music listening

  • < 18 years and > 80 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 AOU Città della Salute e della Scienza Turin Italy 10126

Sponsors and Collaborators

  • Azienda Ospedaliera Città della Salute e della Scienza di Torino

Investigators

  • Study Chair: Andrea MD Bosio, MD, AOU città dellaSalute e della Scienza, Torino
  • Principal Investigator: Andrea MD Bosio, MD, AOU città dellaSalute e della Scienza, Torino
  • Study Director: Andrea MD Bosio, MD, AOU città dellaSalute e della Scienza, Torino

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andrea Bosio, Principal investigator, Azienda Ospedaliera Città della Salute e della Scienza di Torino
ClinicalTrials.gov Identifier:
NCT04338451
Other Study ID Numbers:
  • AOUCSSTURAB001
First Posted:
Apr 8, 2020
Last Update Posted:
Apr 8, 2020
Last Verified:
Apr 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Andrea Bosio, Principal investigator, Azienda Ospedaliera Città della Salute e della Scienza di Torino
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 8, 2020